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Background-—Physical activity is associated with several health benefits, including lower cardiovascular disease risk. The
independent influence of physical activity on cardiac and vascular function in the community, however, has been sparsely
investigated.
Measures and Results-—We related objective measures of moderate- to vigorous-intensity physical activity (MVPA, assessed by
accelerometry) to cardiac and vascular indices in 2376 participants of the Framingham Heart Study third generation cohort (54%
women, mean age 47 years). Using multivariable regression models, we related MVPA to the following echocardiographic and
vascular measures: left ventricular mass, left atrial and aortic root sizes, carotid–femoral pulse wave velocity, augmentation index,
and forward pressure wave. Men and women engaged in MVPA 29.921.4 and 25.519.4 min/day, respectively. Higher values of
MVPA (per 10-minute increment) were associated with lower carotid–femoral pulse wave velocity (estimate 0.53 ms/m;
P=0.006) and lower forward pressure wave (estimate 0.23 mm Hg; P=0.03) but were not associated with augmentation index
(estimate 0.13%; P=0.25). MVPA was associated positively with loge left ventricular mass (estimate 0.006 loge [g/m
2]; P=0.0003),
left ventricular wall thickness (estimate 0.07 mm; P=0.0001), and left atrial dimension (estimate 0.10 mm; P=0.01). MVPA also
tended to be positively associated with aortic root dimension (estimate 0.05 mm; P=0.052). Associations of MVPA with
cardiovascular measures were similar, in general, for bouts lasting <10 versus ≥10 minutes.
Conclusions-—In our community-based sample, greater physical activity was associated with lower vascular stiffness but with
higher echocardiographic left ventricular mass and left atrial size. These findings suggest complex relations of usual levels of
physical activity and cardiovascular remodeling. ( J Am Heart Assoc. 2015;4:e001528 doi: 10.1161/JAHA.114.001528)
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C omparedwith other preventive strategies, physical activitymay be a particularly efficient method of reducing the risk
of future cardiovascular disease (CVD) at the population level
because it modifies several key risk factors simultaneously and
has independent favorable effects on the cardiovascular
system.1 Joint guidelines from the American College of Sports
Medicine and the American Heart Association recommend that
otherwise healthy persons aged 18 to 65 years should engage
in moderate-intensity physical activity for at least 30 minutes
5 days per week (150 minutes per week) or vigorous-intensity
activity for at least 20 minutes at least 3 times per week
(60 minutes per week) to promote and maintain health.2 The
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guidelines emphasize only bouts lasting≥10 minutes (ie, bouts)
in their recommendations. It is unknown whether bouts lasting
<10 minutes per session (ie, nonbouts) have beneficial health
effects. The guidelines acknowledge that increases in physical
activity beyond recommendations may be associated with
additional health benefits but conclude that little is currently
known about whether there is an upper limit of physical activity
at which benefits may level out.2
Although several studies have shown that physical activity is
associated with improvement in several CVD risk factors and
subclinical disease measures in various populations, some
uncertainty remains.3–5 Data on physical activity in relation to
vascular and echocardiographic measures at the community
level are sparse, and a majority of previous epidemiological
studies have been limited by a lack of objective measures on
physical activity. Furthermore, prior studies have not distin-
guished between nonbouts and bouts of exercise, the latter being
emphasized in guidelines, as noted. Accordingly, we conducted a
comprehensive analysis of the association between physical
activity (assessed objectively by accelerometry) and cardiac
structure and vascular function measures in a large community-
based sample of young-adult to middle-aged men and women.
Methods
The study sample comprised participants from the third
generation cohort of the Framingham Heart Study,6 namely,
children of the offspring cohort participants7 and grandchildren
of the original cohort.8 In total, 4095 persons attended the first
examination (2002–2005), and 3411 participated in the second
examination (2008–2011). For the present investigation, we
included those who attended the second examination and who
had valid accelerometry data (validity is defined in “Physical
Actvity”). Fasting blood samples, anthropometric measures,
blood pressure, medical history update, smoking status, and
medication use were obtained at examination cycle 2. We
excluded participants without valid accelerometry data (n=952;
these participants had slightly higher body mass index and a
higher prevalence of diabetes than participants with valid
accelerometry data; full characteristics of participants with and
withoutaccelerometrydataareshowninTable 1),withprevalent
CVD (defined as myocardial infarction, coronary insufficiency,
heart failure, or stroke; n=57), prevalent valve disease (n=22), or
missing covariates (n=2). All participants gave written informed
consent, and the institutional review board at the Boston
University Medical Center approved the study protocols.
Physical Activity
All participants were asked to wear an omnidirectional
accelerometer on the hip for 8 days (Actical model no. 198-
0200-00; Philips Respironics). In total, 2672 (78%) agreed to
do so and had valid accelerometry measures. A thorough
description of the ascertainment of these measures has been
published.9 In brief, participants were asked to wear the
accelerometer throughout the day and night except when they
were bathing. For calculations of sedentary time, we consid-
ered only wear time between 6 AM and 10 PM. The acceler-
ometer recorded signals from nonvertical body movements
within 0.5 to 3 Hz and recorded accelerations or decelera-
tions within 0.05 to 2.0g. Recorded signals were grouped in
“counts” by 30-second intervals and stored on the device.
According to a predefined protocol, all data were manually
reviewed for spurious information; signals likely to be artifacts
were deleted.9 Data were analyzed at the Framingham Heart
Study using customized software (KineSoft, version 3.3.63;
KineSoft). Measures from the first day of wear were not
included in analyses. Accelerometer data were considered
valid if the accelerometer was worn >10 hours per day for at
least 5 of 7 days including at least 1 weekend day.10,11
Based on the counts accrued and regression coefficients
from previously published work,12 moderate-intensity physical
activity was defined as 435 to 2535 counts per 30 seconds
(which corresponds to 3 to 6 metabolic equivalents), and
vigorous-intensity physical activity was defined as ≥2536
counts per 30 seconds (corresponding to >6 metabolic
equivalents). Light physical activity was defined as 100 to
434 counts per 30 seconds, and sedentary time was defined
as <100 counts per 30 seconds. For the present analysis,
data for moderate and vigorous physical activity were pooled
and coded as total minutes per week (denoted as moderate-
to vigorous-intensity physical activity [MVPA]) because very
few people had a significant amount of vigorous activity.
Consistent with current guidelines, MVPA sessions that lasted
<10 minutes were considered nonbouts, and any session that
lasted ≥10 minutes was considered a bout. We defined
compliance with physical activity guidelines in 2 different
ways: as ≥150 minutes of MVPA per week performed in bouts
of ≥10 minutes and as ≥150 minutes total MVPA per week
regardless of the duration. For people with <7 days of valid
wear, we averaged the activity over the valid days and
extrapolated to estimate the MVPA for 7 days (corresponding
to 1 week).
Concomitant strength training (used in sensitivity analyses)
was defined as at least 30 minutes of activities such as snow
shoveling, moving heavy objects, or weight lifting at least 4
times per month during the past 12 months (home or work
related) based on self-reported questionnaire data adminis-
tered at examination cycle 2.
Vascular Measures
All study participants underwent arterial applanation tonometry
investigation after an overnight fast during the second
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examination cycle. Measures were obtained with the partici-
pant in a supine position after approximately 5 minutes of rest.
Pulse wave profiles were obtained by the use of a custom
tonometer (Cardiovascular Engineering Inc). Tonometry and
ECG data were digitally stored and analyzed in a core laboratory
(Cardiovascular Engineering Inc) by trained analysts who were
blinded to data on physical activity. The forward pressure wave
and augmentation index were derived from carotid pressure
waveform measures.13 The augmentation index was calculated
as the augmentation pressure (ie, the difference between first
systolic inflection point and the peak waveform) divided by the
total pulse pressure and multiplied by 100.14 Carotid–femoral
pulse wave velocity (CFPWV) was measured as the distance
between the carotid and femoral sites (adjusted for parallel
transmission) divided by the time delay between the foot of the
carotid and femoral waveforms.14
During the first examination cycle, which was performed, on
average, 6.1 (0.6) years prior to the second examination
cycle, assessments of endothelial function (by flow-mediated
dilation) and shear stress (by baseline and hyperemic artery
flow velocities) were undertaken on the brachial artery using a
commercially available ultrasound system, as described in
detail previously.15,16 Baseline artery flow velocity was mea-
sured with the participants in a resting supine state, and then a
cuff was placed on the upper arm and inflated for 5 minutes. At
15 seconds after cuff deflation, the artery flow velocity was
measured again to derive the peak hyperemic artery flow
velocity. Flow-mediated dilation (percentage) was calculated as
the difference of the brachial artery dimension (60 seconds
after cuff deflation) and the dimension at baseline divided by
baseline dimension. These measures were included as second-
ary analyses to explore the relation of endothelial function in a
medium-sized muscular artery to physical activity.
Echocardiography Measures
Data on transthoracic echocardiogramswere carried forward from
examination cycle 1 for analysis in relation to physical activity (no
echocardiography was performed contemporaneously with ac-
celerometry). Echocardiograms were performed according to a
specified protocol by trained sonographers. Images were stored
on a local hard drive and analyzed by a sonographer and/or a
cardiologist blinded to clinical information. Measures of left
ventricular (LV) structure (interventricular septumand LVposterior
wall thicknesses at end diastole and LV end-diastolic and end-
systolic dimensions) were obtained from M-mode images,
according to American Society of Echocardiography guidelines,
using a leading-edge technique.8 End-diastolic measurements of
the aortic root and end-systolic dimension of the left atrium were
also measured from M-mode images. LV mass (LVM) was
calculated using the American Society of Echocardiography
formula applied by Devereux et al17:
LVM ¼ 0:8f1:04ð½LVIDD+PWTD+IVSTD3  ½LVIDD3Þg
þ 0:6g
In this equation, LVIDD denotes LV end-diastolic dimen-
sion, and PWTD and IVSTD indicate the end-diastolic thick-
nesses of the posterior wall and the interventricular septum,
respectively. We previously reported excellent reproducibility
of echocardiographic measurements at the Framingham Heart
Study.18 LV diastolic function was assessed by the E/e0 ratio
obtained from Doppler tissue imaging, estimated from the
apical 4-chamber view with the transducer placed immediately
apical to the mitral valve (E) and at the LV lateral wall (e0).
Table 1. Characteristics of People With and Without Valid
Accelerometry Data
Valid
Accelerometry
(n=2455)
No Valid
Accelerometry
(n=952)
Age, y 47 (9) 46 (9)*
Sex, women, % 1312 (53) 495 (52)
Body mass index, kg/m2 27.7 (5.5) 28.9 (6.7)**
Systolic blood pressure, mm Hg 116 (14) 116 (14)
Diastolic blood pressure, mm Hg 74 (9) 74 (9)
Total cholesterol, mg/dL 187 (35) 186 (35)
HDL cholesterol, mg/dL 60 (18) 58 (17)*
LDL cholesterol, mg/dL 105 (30) 104 (32)
Antihypertensive medication, % 403 (16) 183 (19)
Lipid-lowering medication, % 400 (16) 164 (17)
Diabetes, % 122 (5) 60 (6)
Current smoker, % 247 (10) 142 (15)**
Echocardiography measures
Left ventricular mass, g/m2 157 (42) 159 (43)
Left ventricular wall thickness
(IVSTD+PWTD), mm
17.9 (2.4) 18.1 (2.4)
Left ventricular
end-diastolic dimension, mm
49.3 (4.0) 49.3 (4.2)
Aortic root dimension, mm 31.2 (3.8) 31.2 (3.7)
E/e0 ratio 5.9 (1.5) 5.8 (1.4)
Left atrial dimension, mm 27.3 (4.5) 27.6 (4.8)
Tonometry measures
CFPWV, m/s 7.1 (1.4) 7.1 (1.6)
1000/CFPWV, ms/m 146 (25) 146 (27)
Augmentation index, % 9.9 (12.6) 10.0 (12.3)
Forward pressure wave, mm Hg 45.6 (10.9) 45.4 (11.2)
CFPWV indicates carotid–femoral pulse wave velocity; HDL, high-density lipoprotein
cholesterol; IVSTD, end-diastolic interventricular septum thickness; LDL, low-density
lipoprotein cholesterol; PWTD, end-diastolic posterior wall thickness.
*P<0.05 difference between groups. **P<0.001 difference between groups.
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Statistical Analyses
Linear regression models were used to assess the relation-
ships between different vascular and echocardiographic
measures (dependent measures) and physical activity (inde-
pendent variable). LVM was naturally log-transformed
because of its skewed distribution, and this reduced
differences in variance between men and women.19 CFPWV
was inverse-transformed and multiplied by 1000 (to reduce
heteroscedasticity and to maintain directionality).20 All
models were adjusted for total wear time (in min/day),
sex, age, height, weight, systolic blood pressure, use of
antihypertensive and lipid-lowering medications, current
smoking status, serum total and high-density lipoprotein
cholesterol concentrations, and diabetes. To ensure that
strength training did not influence the associations of
physical activity (as measured with accelerometry) with
LVM and CFPWV, we performed a sensitivity analysis with
additional adjustment of concomitant strength training
assessed with a questionnaire. Because echocardiographic
measures were not obtained contemporaneously with the
other variables, we estimated additional multivariable models
that also adjusted for measurements of systolic blood
pressure and weight at the time of echocardiographic
measurements (in addition to adjusting for these variables
at the time of accelerometry) as sensitivity analyses. We
calculated estimated changes in LVM associated with
physical activity measures as percentage change in
LVM=1009[exp(regression estimate9increment in physical
activity)1]. We compared estimates for MVPA in bouts
versus nonbouts using the “test” statement in SAS proc reg
(SAS Institute Inc). Multivariable-adjusted cubic splines were
created to graphically display linearity of the observed
associations.21 Because graphic analyses did not reveal
major deviations from linear analyses, we used a linear
model for simpler interpretation. All analyses were per-
formed in SAS version 9.3. A 2-sided P value <0.05 was
considered significant for all analyses. Given the exploratory
nature of the study, we did not make adjustments for
multiple testing.
The authors had full access to the data and take
responsibility for its integrity. All authors read and agreed
with the study as written.
Results
Characteristics of our sample are provided in Table 2. On
average, men and women accumulated 29.921.4 and
25.519.4 min/day in MVPA, but there were large differ-
ences among participants; total daily MVPA accrued varied
from 0.4 to 192 minutes for men and from 0.2 to
157 minutes for women. Most MVPA was carried out in
Table 2. Participant Characteristics
Men
(n=1096)
Women
(n=1280)
Age, y 47 (8) 47 (9)
Body mass index, kg/m2 28.7 (4.6) 26.7 (6.0)
Systolic blood pressure, mm Hg 121 (13) 112 (14)
Diastolic blood pressure, mm Hg 78 (9) 72 (9)
Total cholesterol, mg/dL 188 (36) 187 (35)
HDL cholesterol, mg/dL 51 (14) 68 (18)
LDL cholesterol, mg/dL 111 (29) 101 (30)
Antihypertensive medication, % 207 (19) 160 (12)
Lipid-lowering medication, % 234 (21) 126 (10)
Diabetes, % 58 (5) 47 (4)
Current smoker, % 124 (11) 111 (9)
Echocardiography measures
Left ventricular mass, g/m2 187 (35) 130 (25)
Left ventricular wall thickness
(IVSTD+PWTD), mm
19.5 (2.0) 16.5 (1.7)
Left ventricular end diastolic
dimension, mm
51.6 (3.6) 47.3 (3.2)
Aortic root dimension, mm 33.7 (3.2) 28.9 (2.6)
E/e0 ratio 5.7 (1.4) 6.0 (1.6)
Left atrial dimension, mm 29.1 (4.2) 25.5 (3.9)
Tonometry measures
CFPWV, m/s 7.4 (1.4) 6.8 (1.3)
1000/CFPWV, ms/m 139 (23) 152 (25)
Augmentation index, % 5.2 (12.5) 13.8 (11.3)
Forward pressure wave, mm Hg 47.2 (10.4) 44.1 (10.8)
Activity measures
Total MVPA per week, min 199 (146) 169 (130)
Sedentary time, min/day 657 (71) 670 (65)
Light PA, min/day 143 (54) 132 (45)
Moderate PA, min/day 28.0 (19.6) 22.9 (17.0)
Vigorous PA, min/day 1.9 (5.2) 2.5 (6.4)
MVPA, min/day 29.9 (21.4) 25.5 (19.4)
MVPA ≥10, min/day* 12.6 (12.4) 15.6 (14.1)
MVPA <10 min/day 22.8 (15.9) 16.0 (10.8)
PA guidelines compliance
any MVPA, %
651 (59.4) 618 (48.3)
PA guidelines compliance
MVPA ≥10 only, %
116 (10.6) 194 (15.2)
Leisure time strength training, % 381 (35) 247 (19)
Work time strength training, % 271 (25) 102 (8)
Values are mean (SD) for continuous measures or percentage as indicated. CFPWV
indicates carotid–femoral pulse wave velocity; HDL, high-density lipoprotein cholesterol;
IVSTD, end-diastolic interventricular septum thickness; LDL, low-density lipoprotein
cholesterol; MVPA, moderate- to vigorous-intensity physical activity; PA, physical activity;
PWTD, end-diastolic posterior wall thickness.
*Calculated for those who had at least 1 bout per day (n=613 men and 774 women);
therefore, the sum of MVPA <10 and MVPA ≥10 min/day does not equal total MVPA.
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nonbouts (ie, bouts lasting <10 minutes). The average
sedentary time was 65771 and 67065 min/day among
men and women (minimum to maximum 385 to 816 min/
day for men and 379 to 835 min/day for women),
respectively.
Associations Between Physical Activity and
Vascular Stiffness Measures
The relation of MVPA and CFPWV is depicted in Figure A.
Higher values of MVPA were associated with lower CFPWV
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(estimateSE 0.530.19 ms/m [P=0.006] per 10 minutes
of MVPA per day; 1 SD of MVPA is 20 minutes) (Table 3).
The inverse association between MVPA and CFPWV was not
statistically different for MVPA performed as bouts versus
nonbouts (0.800.30 ms/m [P=0.008] versus
0.450.29 ms/m [P=0.32] per 10 minutes of MVPA per
day; P>0.05 for difference) (Table 3). Adjustment for strength
training did not alter the associations of MVPA with CFPWV
(data not shown). Compliance with guidelines, including both
bout and nonbout activity, was significantly associated with
lower CFPWV (estimate 2.050.78 ms/m [P=0.008], cor-
responding to 1.8 years of age effect; the adjusted estimate
was 1.120.05 ms/m per 1-year older age). There was no
statistically significant association between light physical
activity or sedentary time and CFPWV (Table 3).
MVPA was significantly and inversely associated with the
forward pressure wave (0.230.11 mm Hg per 10 minutes
higher MVPA per day; P=0.03) (Table 3). In addition, light
physical activity was inversely associated with forward
pressure wave (estimate 0.160.05 mm Hg per 10 min-
utes; P=0.0004), whereas sedentary time was not (Table 3).
There were no statistically significant associations between
compliance with physical activity guidelines and forward wave
pressure (Table 3).
For the augmentation index, MVPA in nonbouts was asso-
ciated with higher values, but MVPA in bouts was not
(0.380.17% per 10 min/day for bouts [P=0.02] versus
0.090.17% per 10 min/day for nonbouts [P=0.31];
P=0.03 for difference between associations with augmentation
index forMVPA in bouts versus nonbouts). Light physical activity
was also associated with higher augmentation index values
(0.180.05% [P=0.0002] per 10 minutes of light physical
activity). Compliance with the guidelines and sedentary time
were not associated with the augmentation index (Table 3). In
an exploratory analysis additionally adjusting for resting heart
rate (Table 4), the association of MVPA performed in nonbouts
and augmentation index became statistically nonsignificant,
whereas the association between MVPA performed in bouts
and augmentation index became statistically significant
(0.450.16% [P=0.006] per 10 minutes of MVPA; P=0.02
for difference in association between bouts and nonbouts).
Similarly, compliance with the guidelines including only bouts
was significantly associated with a lower augmentation index
after adjustment for heart rate (1.240.60%; P=0.04).
Associations Between Physical Activity and
Echocardiographic Measures
The relations between MVPA and loge LVM, aortic root
dimension, and left atrial dimension are depicted in Figure –
Panel B through D. Higher mean levels of MVPA were
associated with greater loge LVM (0.0060.002 loge [g/m2]
per 10 min/day; P=0.0003) (Table 5), corresponding to
approximately a 0.6% change in LVM per 10 minutes of
MVPA per day. In additional analyses focused on the 2
components of LVM, the association between MVPA and LVM
appeared to be largely secondary to the association of MVPA
with LV wall thickness (0.070.02 mm per 10 min/day;
P=0.0001) as opposed to LV internal dimensions (0.050.03
mm per 10 min/day; P=0.13). Light physical activity and
Table 3. Relations of Physical Activity to Tonometric Measures of Vascular Stiffness
Carotid–Femoral Pulse Wave
Velocity (ms/m) Augmentation Index (%)
Forward Pressure
Wave (mm Hg)
MVPA
MVPA, per 10 min/day 0.53 (0.19)** 0.13 (0.11) 0.23 (0.11)*
MVPA ≥10 min (bouts), per 10 min/day 0.80 (0.30)** 0.09 (0.17) 0.10 (0.17)
MVPA <10 min (nonbouts), per 10 min/day 0.45 (0.29) 0.38 (0.17)* 0.44 (0.16)**
PA guideline compliance, any MVPA
(bouts or nonbouts)
2.05 (0.78)** 0.40 (0.45) 0.68 (0.43)
PA guideline compliance
(only bouts of MVPA considered)
1.82 (1.10) 0.14 (0.63) 0.61 (0.61)
Light activity
Per 10 min/day 0.13 (0.09) 0.18 (0.05)*** 0.16 (0.05)***
Sedentary time
Per 10 min/day 0.07 (0.06) 0.06 (0.03) 0.04 (0.03)
All association estimates are presented as estimates (SE). All models were performed with tonometry measures as the dependent variables and were adjusted for total wear time, sex, age,
height, weight, systolic blood pressure, use of antihypertensive and lipid-lowering medications, current smoking status, serum total and high-density lipoprotein cholesterol concentrations,
and diabetes. Tests for differences in association between MVPA in bouts vs nonbouts were not significant for all measures except for augmentation index (P=0.03). MVPA indicates
moderate- to vigorous-intensity physical activity; PA, physical activity.
*P<0.05, **P<0.01, ***P<0.001.
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compliance with the guidelines were also associated with
greater loge LVM (Table 5). Sedentary behavior was associ-
ated with lower LV wall thickness and loge LVM (0.002 g/
m2 changes in loge LVM, corresponding to 0.2% lower LVM,
per 10 minutes of sedentary behavior).
MVPA was borderline significantly and positively associ-
ated with aortic root size and left atrial dimension, whereas
compliance with guidelines was not associated with either
measure (Table 5). Light physical activity was also positively
associated with higher aortic root size, whereas sedentary
time was associated with lower aortic root size. Adjustment
for strength training did not alter the associations of MVPA
with echocardiographic measures (data not shown). Further
adjustment for weight and systolic blood pressure at time
of echocardiography yielded similar results (data not
shown).
No significant association was noted between physical
activity or sedentary time and E/e0 ratio.
Table 4. Association of Different Measures of Physical Activity With Augmentation Index
Augmentation Index (%)
Without HR With HR
MVPA, per 10 min/day 0.13 (0.11) 0.12 (0.10)
MVPA ≥10 min (bouts), per 10 min/day 0.09 (0.17) 0.45 (0.16)**
MVPA <10 min (nonbouts), per 10 min/day 0.38 (0.17)* 0.15 (0.16)
PA guideline compliance, any MVPA
(bouts or nonbouts)
0.40 (0.45) 0.58 (0.43)
PA guideline compliance
(only bouts of MVPA considered)
0.14 (0.63) 1.24 (0.60)*
Light PA, per 10 min/day 0.18 (0.05)*** 0.15 (0.05)***
Sedentary time, per 10 min/day 0.06 (0.03) 0.04 (0.03)
All association estimates are presented as b values (SE). All models were performed with augmentation index as the dependent variables and were adjusted for total wear time, sex, age,
height, weight, systolic blood pressure, use of antihypertensive and lipid-lowering medications, current smoking status, serum total and high-density lipoprotein cholesterol concentrations,
and diabetes. HR indicates heart rate; MVPA, moderate- to vigorous-intensity physical activity; PA, physical activity.
*P<0.05, **P<0.01, ***P<0.001.
Table 5. Relations of Physical Activity and Echocardiographic Measurements
Loge Left Ventricular
Mass (g/m2)
LV End-Diastolic
Dimension (mm)
LV Wall
Thickness (mm)
Aortic Root
Dimension (mm)
Left Atrial
Dimension (mm) E/e0 Ratio
Moderate to vigorous PA
MVPA, per 10 min/day 0.006 (0.002)*** 0.05 (0.03) 0.07 (0.02)*** 0.05 (0.03) 0.10 (0.04)* 0.01 (0.01)
MVPA ≥10 min (bouts),
per 10 min/day
0.009 (0.003)** 0.11 (0.05)* 0.07 (0.03)** 0.03 (0.04) 0.13 (0.06)* 0.02 (0.02)
MVPA <10 min (nonbouts),
per 10 min/day
0.007 (0.003)* 0.01 (0.05) 0.09 (0.03)** 0.09 (0.04)* 0.11 (0.06) 0.01 (0.02)
PA guideline compliance, any
MVPA (bouts or nonbouts)
0.019 (0.007)** 0.19 (0.14) 0.18 (0.07)** 0.21 (0.11) 0.12 (0.15) 0.03 (0.06)
PA guideline compliance
(only bouts of MVPA considered)
0.018 (0.010) 0.31 (0.19) 0.10 (0.10) 0.03 (0.16) 0.20 (0.22) 0.14 (0.08)
Light activity
Per 10 min/day 0.002 (0.0008)** 0.04 (0.02)** 0.01 (0.008) 0.03 (0.01)** 0.02 (0.02) 0.001 (0.006)
Sedentary time
Per 10 min/day 0.002 (0.0005)*** 0.004 (0.01) 0.03 (0.005)*** 0.026 (0.09)** 0.01 (0.01) 0.003 (0.005)
All association estimates are presented as estimates (SE). All models were performed with echocardiographic measures as the dependent variables and were adjusted for total wear time,
sex, age, height, weight, systolic blood pressure, use of antihypertensive and lipid-lowering medications, current smoking status, serum total and high-density lipoprotein cholesterol
concentrations, and diabetes. Because left ventricular mass was log-transformed (base e), the association of physical activity on untransformed left ventricular mass is multiplicative,
estimated by an exponentiated regression coefficient. Tests for difference in association between MVPA in bouts vs nonbouts were not significant for all measures (P>0.05). MVPA
indicates moderate- to vigorous-intensity physical activity; PA, physical activity.
*P<0.05, **P<0.01, ***P<0.001.
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Secondary Analyses
Hyperemic flow velocity and flow-mediated dilation were not
significantly associated with any of the physical activity
measures (Table 6). Baseline flow velocity was significantly
and inversely associated with MVPA performed in bouts
(0.160.07 cm/s per 10 minutes of MVPA; P=0.016) and
with sedentary time (0.040.01 cm/s per 10 minutes of
sedentary behavior; P=0.007).
Discussion
In our large study of middle-aged ambulatory community-
dwelling participants, higher mean levels of MVPA were
associated with lower arterial stiffness, greater LVM, and
greater aortic root and left atrial sizes compared with physical
inactivity after adjustment for potential confounders. Compli-
ance with current guidelines (ie, engaging in at least
150 minutes per week of MVPA) was associated with 1%
lower CFPWV, corresponding to a reduction in vascular aging
of 1.8 years. Sedentary behavior was associated inversely
with LVM and aortic root but not with vascular stiffness
measures.
Consistent with our study, smaller observational studies
(also cross-sectional) in the general population and in patients
with type 2 diabetes22–24 and short-term interventional
studies of postmenopausal women25 and middle-aged men
have reported lower central arterial stiffness with increasing
levels of physical activity.23 Because CFPWV has been
reported to be a strong predictor of hypertension and CVD
in the community,20,26 the associations of compliance with
guidelines and lower CFPWV may have important implications
for reducing long-term cardiovascular risk.
Increased arterial stiffness is usually considered the result
of exposure to several hemodynamic and systemic adverse
factors such as hypertension, advancing age, diabetes,
atherosclerosis, and inflammation. Arterial stiffening may
result from both passive (increased intima-media thickness)
and active (smooth vascular muscle tone) components, both
of which can be altered by physical activity.27 Typically,
intima-media thickness increases by 2- to 3-fold during the
adult life course.28 Some observational studies have reported
previously that questionnaire-based measurement of physical
activity is associated with attenuated age-related increases in
intima-media thickness in adolescent,29 middle-aged, and
elderly persons,30 although not all studies have yielded
consistent results.31,32 The active component responsible for
increases in arterial stiffness relates to heightened smooth
vascular muscle tone and endothelial dysfunction.27 Triggers
for high muscular tone include mechanical stimulation,
endocrine factors such as angiotensin, and oxidative
stress.27 Physical activity has been associated previously
with healthier endothelial function in a cross-sectional study
of middle-aged men.33 Furthermore, a recent study of 114
previously sedentary older adults aged ≥50 years demon-
strated improved flow-mediated dilation (a marker of endo-
thelial function) among those who increased moderate
physical activity levels in bouts of ≥10 minutes for at least
≥20 minutes per day over a 12-week period.34 In our
analyses, however, MVPA was not associated with endothe-
lial-dependent measures (ie, flow-mediated dilation). It is
conceivable that the temporal difference between accele-
rometry and forearm vascular measures may have introduced
misclassification that could have masked a true positive
association between flow-mediated dilation and MVPA in our
study.
Table 6. Association of Different Measures of Physical Activity With Brachial Artery Measures
Baseline Flow Velocity (cm/s) Hyperemic Flow Velocity (cm/s) Flow-Mediated Dilation (%)
MVPA, per 10 min/day 0.05 (0.04) 0.19 (0.20) 0.002 (0.04)
MVPA ≥10 min (bouts), per 10 min/day 0.16 (0.07)*† 0.26 (0.31) 0.04 (0.06)
MVPA <10 min (nonbouts), per 10 min/day 0.03 (0.07)† 0.19 (0. 30) 0.03 (0.06)
PA guideline compliance, any MVPA
(bouts or nonbouts)
0.28 (0.17) 0.51 (1.13) 0.11 (0.15)
PA guideline compliance
(only bouts of MVPA considered)
0.25 (0.24) 0.86 (0.81) 0.25 (0.21)
Light PA, per 10 min/day 0.009 (0.02) 0.033 (0.088) 0.0007 (0.02)
Sedentary time, per 10 min/day 0.04 (0.01)** 0.03 (0.06) 0.007 (0.01)
All association estimates are presented as b values (SE). All models were performed with vascular measures as the dependent variables and were adjusted for total wear time, sex, age,
height, weight, systolic blood pressure, use of antihypertensive and lipid-lowering medications, current smoking, serum total and high-density lipoprotein cholesterol concentrations, and
diabetes. MVPA, moderate- to vigorous-intensity physical activity; PA,physical activity.
†P=0.01 for difference between MVPA performed as bouts vs nonbouts.
*P<0.05, **P<0.01, ***P<0.001.
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Cardiac remodeling secondary to physical activity has
predominantly been studied in trained athletes. Endurance
athletes often have eccentric hypertrophy (ie, increased
LV internal dimension and stroke volume), whereas
strength-trained athletes develop concentric hypertrophy35;
however, LV area was also reported to increase by approxi-
mately 5.5% in a 12-week program of moderate exercise (ie,
brisk walk or jogging at a heart rate ≥120 beats per minute) in
young and middle-aged sedentary men and women.36 In
contrast, periods of physical inactivity, as tested in bed-rest
trials, have been shown to cause significant reductions in LVM
(ranging on average between 8% and 16% for 6 and 12 weeks
of bed rest, respectively).37,38 In the present study, we
confirmed that typical levels of physical activity (of a magni-
tude much lower than that of athletes) were associated with
overall modest increments in LVM. Compared with the average
MVPA of 30 minutes per day, the participant with the highest
accrued MVPA per day (192 minutes per day) would have an
estimated increase in LVM, based on our estimates, of 1009
(exp(0.0069(19230 min)/10 min1)=10.2%. In contrast,
compared with the average sedentary time of 657 min/day,
the person with highest sedentary time (835 sedentary min/
day) would have estimated lower LVM of 1009(exp(0.0029
(835657 min)/10 min1)=3.5%. A significant positive asso-
ciation of LVM with a questionnaire-based measure of leisure
time physical activity was reported nearly 25 years ago from
the Framingham Heart Study offspring cohort (although the
association was statistically significant only in men in that
study), but given the temporal and methodological differences,
it is challenging to compare the results of the present
investigation with the findings in the previous study.39
In the present study, the cardiac remodeling associated with
greater MVPA was driven by the association with greater
increases in LVwall thickness (ie, concentric remodeling) rather
than increases in LV end-diastolic dimensions (ie, eccentric
remodeling). Such a remodeling pattern may also be apparent
under pathological conditions like hypertension, but under
these conditions, vascular stiffness is likely to be increased,
and LV diastolic function is also likely to be impaired. In the
present study, MVPAwas inversely related to vascular stiffness,
and there was no association with LV diastolic function as
measured by the E/e0 ratio, suggesting that the pattern of LV
remodeling seen in physical activity at levels typically observed
in the community is likely benign.40 Other studies have even
indicated that, despite increases in LVM following physical
activity, LV diastolic function assessed by sensitive tissue
Doppler measures may be supranormal.41,42
We observed a significant association between higher levels
of physical activity and greater dimension of left atrium and
borderline significant associations of physical activity with
aortic root dimension. To the best of our knowledge, this result
has not been reported previously in people in the community
engaging in nonextreme ranges of physical activity. Studies of
very well-trained athletes have reported increases in both atrial
and aortic root dimensions, especially in endurance-trained
athletes, who experience greater hemodynamic loads com-
pared with strength-trained athletes.43–45 Themagnitude of the
association between physical activity and aortic root dimen-
sions was very modest and was unlikely to be associated with
any clinical consequence. Even in very well-trained athletes,
aortic root dimensions very rarely exceeded >40 mm in male
athletes and >34 mm in female athletes.44 Left atrial size has
been shown to be increased in endurance-trained athletes and
may increase the risk of lone atrial fibrillation46; however, we
observed very modest increases in left atrial dimensions with
greater physical activity, and these were likely of little clinical
relevance. Additional studies are needed to evaluate the long-
term consequences of the modest increments in LVM, aortic
root size, and left atrial dimensions observed with increasing
MVPA.
Impact of Bout Duration on the Cardiovascular
System
The importance of bouts versus nonbouts of physical activity
for cardiovascular health has not been well investigated.
Among previously sedentary, overweight women, a random-
ized trial demonstrated that those randomized to long bouts
of exercise had similar improvements in cardiorespiratory
fitness as those randomized to equivalent amounts of
exercise in short bouts over an 18-month period.47,48 It has
been speculated that long bouts of physical activity may
generate more free oxygen radicals than what the endoge-
nous antioxidant system can neutralize49,50 and thus may
increase arterial stiffness (as suggested by a study of physical
activity in patients with established CVD).51 In contrast, in a
recent study of previously sedentary adults aged ≥50 years,
Suboc et al observed improved flow-mediated dilation for
those who engaged for ≥20 min/day in moderate physical
activity with bouts lasting ≥10 minutes but not for those who
engaged in moderate physical activity with bouts lasting
<10 minutes.34 The authors of that report did not observe a
statistically significant association of moderate physical
activity with CFPWV or augmentation index.34 In our study,
we found no evidence of differential associations of short
versus long bout duration on arterial stiffness, suggesting that
physical activity of any duration may have beneficial effects
on vascular stiffness.
Strengths and Limitations
The large community-based sample, comprehensive assess-
ment of physical activity (including sedentary time and light
physical activity) and vascular stiffness, and echocardiographic
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measurements (including diastolic function) strengthen our
investigations. Nonetheless, several limitations merit com-
ment. The present study was observational and cross-sectional
in design and thus precludes causal inferences. Although we
adjusted all models for multiple variables, the influence of
residual confounding cannot be excluded. In addition, accele-
rometry does not capture resistance training. The study sample
was mainly composed of white participants of European
descent, thereby limiting generalizability to other ethnicities.
Furthermore, the echocardiographic measurements were
obtained prior to accelerometry, and that can result in an
underestimation of the strength of the associations between
MVPA and cardiac measurements (regression dilution bias).
Although we performed multiple analyses, we did not account
for multiple statistical testing in our reporting of our results;
several of our findings may be considered hypothesis gener-
ating and warrant replication in subsequent studies. Finally,
notwithstanding the statistical significance of selected associ-
ations noted in our analyses, the effect sizes observed (for LVM
and left atrial and aortic root dimensions) are modest and may
not be clinically important.
Conclusions and Clinical Perspective
Physical activity was associated with favorable effects on
arterial stiffness and with very modest increments in LVM and
aortic root and left atrial size. Compliance with the guidelines
was associated with 1% lower CFPWV comparable to having
vascular stiffness that is 1.8 years younger than actual
chronological age. Bouts lasting ≥10 and <10 minutes of
duration were shown to have no overall differential effects on
our subclinical vascular and cardiac measures, suggesting that
physical activity, regardless of duration, may have similar
associated beneficial effects on the cardiovascular system. A
recent study estimated that the population life expectancy in
the United States will increase by 2 years if adults reduce their
time sitting to <3 hours per day.52 Our results demonstrated
that sedentary behavior was associated with an adjusted
inverse relation with LVM. Although we did not observe any
statistically significant inverse associations between sedentary
time and arterial stiffness measures, other studies have
suggested that physical inactivity is a significant risk factor
for CVD independent of physical activity levels.53,54 Conse-
quently, physical inactivity should be considered as a CVD risk
factor, notwithstanding the lack of association with vascular
stiffness measures in the present report.
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